Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fluvoxamine Maleate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 422Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.

    22 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217917

    FDA
    22 Jan 2024
    Share Share
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.

    22 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217917

    FDA
    22 Jan 2024
    Share Share
    FDA nixes EUA ambitions for Eiger’s COVID treatment
    FDA nixes EUA ambitions for Eiger’s COVID treatment

    06 Oct 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/fda-nixes-eua-ambitions-eigers-covid-treatment-proposes-full-approval-pathway-instead

    Max Bayer FIERCEBIOTECH
    06 Oct 2022
    Share Share
    FDA rejects cheap, generic SSRI as a Covid-19 drug
    FDA rejects cheap, generic SSRI as a Covid-19 drug

    17 May 2022

    // Z. Brennan ENDPTS

    https://endpts.com/unpersuaded-by-the-data-fda-rejects-cheap-generic-ssri-as-a-covid-19-drug/

    Z. Brennan ENDPTS
    17 May 2022
    Share Share
    How a Controversial Off-Patent Psychiatric Treatment Went Legit?
    How a Controversial Off-Patent Psychiatric Treatment Went Legit?

    21 Jan 2022

    // TRIALSITENEWS

    https://trialsitenews.com/fluvoxamines-moment-how-a-controversial-off-patent-psychiatric-treatment-went-legit/

    TRIALSITENEWS
    21 Jan 2022
    Share Share
    University of Minnesota PI Submits EUA Application to FDA for Fluvoxamine
    University of Minnesota PI Submits EUA Application to FDA for Fluvoxamine

    27 Dec 2021

    // TRIALSITENEWS

    https://trialsitenews.com/university-of-minnesota-pi-submits-eua-application-to-fda-for-fluvoxamine/

    TRIALSITENEWS
    27 Dec 2021
    Share Share